Announcements

Husam Younis, Chief Scientific Officer of Atrium Therapeutics, Inc., filed a statement of changes in beneficial ownership on September 22, 2026, reporting a transaction in the company's common stock dated September 18, 2026.

Jose Miguel Oxholm, Chief Legal and Compliance Officer of Hyliion Holdings Corp., filed a statement of changes in beneficial ownership on September 22, 2026, disclosing a charitable gift of common stock transacted on September 21, 2026.

A Form 4 filed with the SEC on September 22, 2026, discloses that Roberto Mignone, a director at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), reported the sale of 367,600 ordinary shares on September 18, 2026, held indirectly through Swiftcurrent Master Fund Ltd.

Brian Savage, Interim Chief Legal Officer of Teva Pharmaceutical Industries Ltd., filed a Form 4 on September 22, 2026, reporting option exercises and open-market sales of ordinary shares that took place on September 18, 2026.

A Form 4 filed on September 22, 2026 reports that Jeffrey Mathew, SVP and Chief Information Officer of Frontier Group Holdings, Inc. (NASDAQ:ULCC), received 65,445 shares of common stock from the vesting of Restricted Stock Units and had 18,818 shares withheld to cover tax …

Geoffrey C. Smith, Chief Financial Officer of i3 Verticals, Inc. (NASDAQ:IIIV), a technology and services company, filed a statement of changes in beneficial ownership on September 22, 2026, reporting a share disposition tied to the vesting of restricted stock units originally granted on September …

John Bryan Kitchen, Chief Executive Officer and Director of Ascent Industries Co., filed a statement of changes in beneficial ownership on September 22, 2026, reporting a disposition of common stock on September 21, 2026.